| 12448289 |
Method of nitrogen-phosphorus doped porous carbon for oxygen reduction electrocatalysis within a wide PH range |
Lanyan XU, Jifa Qi, Haishen Jiang, Peikang BAI, Baili Jin +1 more |
2025-10-21 |
|
| 11807651 |
Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile |
Charles Todd Eary, Stacey Spencer, Zack Crane, Katelyn Chando, Sylvie M. Asselin +6 more |
2023-11-07 |
|
| 11760709 |
Method for preparing resorcinol through micro-channel reaction |
Yantao Hao, Guodong Liang, Qinqin Gao, Pengshuai Li, Ting Zhang |
2023-09-19 |
|
| 11098064 |
Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbontrile |
Charles Todd Eary, Stacey Spencer, Zack Crane, Katelyn Chando, Sylvie M. Asselin +6 more |
2021-08-24 |
|
| 10835533 |
1 -((3S,4R)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1H-pyrazol-5-yl)urea as a TrkA kinase inhibitor |
Shelley Allen, Steven W. Andrews, Brian Baer, Zackary Crane, Daniel J. Watson |
2020-11-17 |
|
| 10745419 |
Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile |
Charles Todd Eary, Stacey Spencer, Zack Crane, Katelyn Chando, Sylvie M. Asselin +6 more |
2020-08-18 |
|
| 10729678 |
Preparation of and formulation comprising a MEK inhibitor |
Christoph Max Krell, Marian Misun, Daniel Andreas Niederer, Werner Heinz Pachinger, Marie-Christine Wolf +3 more |
2020-08-04 |
|
| 10398683 |
Preparation of and formulation comprising a MEK inhibitor |
Christoph Max Krell, Marian Misun, Daniel Andreas Niederer, Werner Heinz Pachinger, Marie-Christine Wolf +3 more |
2019-09-03 |
|
| 10329288 |
Process for preparing a compound |
Chong Han, Keena Lynn Green, Francis Gosselin, Michelangelo Scalone, Paul Nichols +4 more |
2019-06-25 |
|
| 9980944 |
Preparation of and formulation comprising a MEK inhibitor |
Christoph Max Krell, Marian Misun, Daniel Andreas Niederer, Werner Heinz Pachinger, Marie-Christine Wolf +3 more |
2018-05-29 |
$21,777,000 |
| 9598376 |
Preparation of and formulation comprising a MEK inhibitor |
Christoph Max Krell, Marian Misun, Daniel Andreas Niederer, Werner Heinz Pachinger, Marie-Christine Wolf +3 more |
2017-03-21 |
$39,692,000 |
| 9562016 |
Preparation of and formulation comprising a MEK inhibitor |
Christoph Max Krell, Marian Misun, Daniel Andreas Niederer, Werner Heinz Pachinger, Marie-Christine Wolf +3 more |
2017-02-07 |
$15,814,000 |
| 9382212 |
Preparation of and formulation comprising a MEK inhibitor |
Christoph Max Krell, Marian Misun, Daniel Andreas Niederer, Werner Heinz Pachinger, Marie-Christine Wolf +3 more |
2016-07-05 |
$6,535,000 |
| 9238627 |
Preparation of and formulation comprising a MEK inhibitor |
Christoph Max Krell, Marian Misun, Daniel Andreas Niederer, Werner Heinz Pachinger, Marie-Christine Wolf +3 more |
2016-01-19 |
$7,073,000 |
| 8648087 |
N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases |
Joseph P. Lyssikatos, Julie Marie Greschuk, Fredrik P. Marmsater, Qian Zhao, D. David Hennings |
2014-02-11 |
$7,569,000 |
| 8299021 |
Macrocyclic inhibitors of hepatitis C virus replication |
Lawrence M. Blatt, Scott D. Seiwert, Steven W. Andrews, Pierre Martin, Andreas Schumacher +10 more |
2012-10-30 |
|
| 7829665 |
Macrocyclic inhibitors of hepatitis C virus replication |
Lawrence M. Blatt, Scott D. Seiwert, Steven W. Andrews, Pierre Martin, Andreas Schumacher +10 more |
2010-11-09 |
$24,983,000 |
